Nuclera News Read our latest press releases and news developments "> FEATURED NEWS Nuclera extends Series C funding to $87M to advance antibody engineering Load More Filter by News TypeCompany AnnouncementsGeneral NewsInvestor NewsYear202120222023202420252026 Open Filter General News Nuclera eProtein Discovery System installed at leading Universities in Taiwan January 7, 2026 Company Announcements General News Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand November 3, 2025 General News Nuclera and Cytiva Join Forces to Accelerate Drug Discovery May 28, 2025 Company Announcements General News Nuclera Expands Global Footprint with New Distribution Partnerships Across APAC and the Middle East May 6, 2025 General News Nuclera Expands eProtein Discovery™ with New Membrane Protein Workflow April 16, 2025 General News Nuclera awarded the National Cyber Security Centre’s (NCSC) Cyber Essentials Plus certification April 8, 2025 General News Nuclera Achieves 47th Spot on Sifted 100: UK & Ireland Leaderboard April 1, 2025 General News Nuclera enters into AI/ML protein design through a partnership with Google Cloud December 19, 2023 General News Nuclera awarded a Biomedical Catalyst Grant from Innovate UK with AI partner DeepMirror December 6, 2023 General News Nuclera Announces Professor Michael Jewett as new member of the Scientific Advisory Board October 24, 2022 Pages: 12Load More News